The Bank of Ireland Kernel Capital Growth Fund (NI) has led a £1.2 million investment in Queens University Belfast (QUB) spin-out Causeway Sensors, in syndication with QUBIS and private investors. Causeway Sensors has availed of Invest Northern Ireland support for Research & Development. Further funding was secured from Innovate UK.

Causeway Sensors’ solution addresses the global problem of antibiotic resistance, which, according to the World Health Organisation, is at dangerously high levels and is one of the biggest threats to global health, food security, and development today. The Company have developed a novel method of distinguishing between a viral and bacterial infection in a real-time point-of-care setting, enabling a reduction in the ineffective use of antibiotics for viral infections.